Synthesis and Characterization of Compounds Potentially Related to the Janus Kinase Inhibitor Baricitinib

被引：2
|
作者：
Dasari, S. R. [1 ,2 ]
Seelam, N. [1 ]
Jayachandra, S. [2 ]
Vadali, L. R. [2 ]
Yerva, E. R. [2 ]
Tondepu, S. [3 ]
Gadakar, M. K. [2 ]
机构：
[1] Koneru Lakshmaiah Educ Fdn, Dept Chem, Guntur, Andhra Pradesh, India
[2] Mylan Labs Ltd, Hyderabad, Telangana, India
[3] Vignans Fdn Sci Technol & Res, Dept Chem Engn, Guntur, Andhra Pradesh, India
来源：
RUSSIAN JOURNAL OF ORGANIC CHEMISTRY | 2019年 / 55卷 / 10期
关键词：
Baricitinib; rheumatoid arthritis; synthesis; characterization; Baricitinib-related substances; INDOLES;
D O I：
10.1134/S1070428019100166
中图分类号：
O62 [有机化学];
学科分类号：
070303 ; 081704 ;
摘要：
Nine compounds potentially related to the Janus kinase inhibitor Baricitinib have been identified, synthesized by conventional methods, and characterized by IR, H-1 and C-13 NMR, and mass spectral data.
引用
收藏
页码：1569 / 1574
页数：6
相关论文
共 50 条
  • [1] Synthesis and Characterization of Compounds Potentially Related to the Janus Kinase Inhibitor Baricitinib
    S. R. Dasari
    N. Seelam
    S. Jayachandra
    L. R. Vadali
    E. R. Yerva
    S. Tondepu
    M. K. Gadakar
    Russian Journal of Organic Chemistry, 2019, 55 : 1569 - 1574
  • [2] Janus-Kinase-Inhibitor Baricitinib in rheumatoid Arthritis
    Alten, R.
    Nitschmann, S.
    INTERNIST, 2017, 58 (12): : 1341 - 1344
  • [3] Direct Effects of the Janus Kinase Inhibitor Baricitinib on Sensory Neurons
    Vazquez, Enrique
    Richter, Frank
    Natura, Gabriel
    Koenig, Christian
    Eitner, Annett
    Schaible, Hans-Georg
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2024, 25 (22)
  • [4] Treatment of Mucous Membrane Pemphigoid With Janus Kinase Inhibitor Baricitinib
    Sarny, Stephanie
    Hucke, Miriam
    El-Shabrawi, Yosuf
    JAMA OPHTHALMOLOGY, 2018, 136 (12) : 1420 - 1422
  • [5] A case of widespread molluscum contagiosum caused by baricitinib, a Janus kinase inhibitor
    Wong, Gwyneth Natalie
    Lee, Senhong
    Foley, Peter
    AUSTRALASIAN JOURNAL OF DERMATOLOGY, 2019, 60 (04) : E334 - +
  • [6] Improvement of cutaneous inflammation and panniculitis in patients with dermatomyositis by the Janus kinase inhibitor baricitinib
    Fischer, Kristina
    Aringer, Martin
    Steininger, Julian
    Heil, Julius
    Beissert, Stefan
    Abraham, Susanne
    Gunther, Claudia
    BRITISH JOURNAL OF DERMATOLOGY, 2022, 187 (03) : 432 - 435
  • [7] Efficacy of Janus kinase 1 and 2 inhibitor baricitinib in multirefractory cutaneous dermatomyositis
    Karaa, S.
    Cassius, C.
    Jachiet, M.
    Mahevas, T.
    Charvet, E.
    Benveniste, O.
    Bouaziz, J. -D.
    ANNALES DE DERMATOLOGIE ET DE VENEREOLOGIE, 2023, 150 (03): : 243 - 245
  • [8] DFT study on the structural and chemical properties of Janus kinase inhibitor drug Baricitinib
    Sonia, Chiging
    Devi, Th. Gomti
    Karlo, T.
    MATERIALS TODAY-PROCEEDINGS, 2022, 65 : 2586 - 2595
  • [9] Janus kinase inhibitor baricitinib is not an ideal option for management of COVID-19
    Praveen, D.
    Puvvada, Ranadheer Chowdary
    Aanandhi, Vijey M.
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2020, 55 (05)
  • [10] Janus Kinase inhibitor Baricitinib Modulates human innate and adaptive immune system
    Kubo, Satoshi
    Nakayamada, Shingo
    Sakata, Kei
    Kitanaga, Yukihiro
    Ma, Xiaoxue
    Lee, Seunghyun
    Ishii, Akina
    Yamagata, Kaoru
    Nakano, Kazuhisa
    Tanaka, Yoshiya
    FRONTIERS IN IMMUNOLOGY, 2018, 9
12345